In the body of patients with IBD, the damaged intestinal barrier could upgrade the expression of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin−1β (IL-1β), which exacerbated the inflammatory response (4, 5). Here, TNF is linked to inflammatory bowel disease.